Cardiff Oncology SG&A Expense (Quarterly) Insights

Cardiff Oncology Inc (CRDF)

3.64 -0.10 (-2.67%) USD | NASDAQ | May 17, 16:00

3.64 0.00 (0.00%) After-Hours: 16:58

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2011. Upgrade now.

Date	Value
March 31, 2024	3.13M
December 31, 2023	2.725M
September 30, 2023	2.939M
June 30, 2023	4.296M
March 31, 2023	3.083M
December 31, 2022	3.078M
September 30, 2022	3.077M
June 30, 2022	3.086M
March 31, 2022	3.94M
December 31, 2021	3.835M
September 30, 2021	2.93M
June 30, 2021	2.838M
March 31, 2021	2.235M
December 31, 2020	3.417M
September 30, 2020	1.644M
June 30, 2020	1.669M
March 31, 2020	1.486M
December 31, 2019	1.517M
September 30, 2019	1.440M
June 30, 2019	1.428M
March 31, 2019	1.375M
December 31, 2018	-4.636M
September 30, 2018	3.330M
June 30, 2018	2.151M
March 31, 2018	2.505M

Date	Value
December 31, 2017	1.875M
September 30, 2017	4.080M
June 30, 2017	4.674M
March 31, 2017	3.605M
December 31, 2016	4.688M
September 30, 2016	5.652M
June 30, 2016	5.598M
March 31, 2016	7.062M
December 31, 2015	4.099M
September 30, 2015	3.747M
June 30, 2015	3.917M
March 31, 2015	2.601M
December 31, 2014	2.710M
September 30, 2014	2.007M
June 30, 2014	1.900M
March 31, 2014	1.928M
December 31, 2013	1.610M
September 30, 2013	2.206M
June 30, 2013	1.479M
March 31, 2013	1.707M
December 31, 2012	1.004M
September 30, 2012	0.739M
June 30, 2012	0.8099M
March 31, 2012	0.827M
December 31, 2011	0.6025M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.428M

Minimum

Jun 2019

4.296M

Maximum

Jun 2023

2.690M

Average

2.934M

Median

SG&A Expense (Quarterly) Benchmarks